Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Altrius Capital Management Inc

Altrius Capital Management Inc increased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 463,895 shares of the pharmacy operator’s stock after purchasing an additional 23,412 shares during the period. Altrius Capital Management Inc’s holdings in Walgreens Boots Alliance were worth $4,328,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of WBA. Brooklyn Investment Group increased its holdings in Walgreens Boots Alliance by 21.1% in the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock valued at $44,000 after purchasing an additional 830 shares during the last quarter. First Financial Corp IN grew its stake in shares of Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares in the last quarter. Lincluden Management Ltd. raised its holdings in shares of Walgreens Boots Alliance by 0.4% in the 3rd quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock valued at $2,371,000 after buying an additional 1,074 shares during the period. CWA Asset Management Group LLC lifted its stake in Walgreens Boots Alliance by 9.2% during the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after acquiring an additional 1,084 shares in the last quarter. Finally, OLD Second National Bank of Aurora boosted its holdings in Walgreens Boots Alliance by 35.1% during the 3rd quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator’s stock valued at $41,000 after acquiring an additional 1,185 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Royal Bank of Canada increased their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday. Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Finally, Evercore ISI boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $12.63.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $11.23 on Friday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The stock has a 50 day moving average price of $10.48 and a 200 day moving average price of $9.72. The company has a market capitalization of $9.70 billion, a price-to-earnings ratio of -1.10, a price-to-earnings-growth ratio of 1.31 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period last year, the firm posted $0.66 EPS. The company’s revenue was up 7.6% on a year-over-year basis. Research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.